Our AI-powered, state-of-the-art manufacturing sites are the bridge between scientific advances and transformative immunizations serving millions of people around the world.
Did you know?
70 %
1.3 million
vaccine doses supplied everyday
1st
global producer of influenza vaccines
Transforming Manufacturing with Modulus
In 2024, Sanofi expanded its global industrial footprint with two cutting-edge Modulus facilities in Neuville, France, and Singapore. These unique production spaces represent the future of manufacturing, offering unprecedented flexibility and responsiveness across vaccine and biological platforms.
The Benefits of Modulus:
- Simultaneous Production: Up to 4 vaccines or biomedicines can be produced simultaneously on the same production site
- Rapid Changeover: Production transitions reduced from months to days, as little as 7 to 10 days
- Sustainability: Meets the highest environmental standards with optimized waste management and 100% renewable electricity
This innovative approach enhances our ability to respond swiftly to global health needs while maintaining the highest quality and sustainability standards.
Vaccine Excellence: From Lab to Vial and Beyond
Vaccine manufacturing is a complex process that shepherds sensitive biological material from the lab to the vial and beyond.
Our vaccines are held to the highest standard of safety. Prior to the approval by the health authorities, our vaccines are tested extensively to ensure they are effective and safe. Once in use, they are also continually monitored for safety through our pharmacovigilance system. Sanofi develops, manufactures and distributes vaccines that respect regulatory requirements and our company’s values.
We are committed to making the safest and most effective vaccines possible available everywhere in the world.
Our Global Manufacturing Footprint
Learn more about Vaccines:
Vaccines Research & Development: Fighting Infectious Diseases
Driving Excellence in Biopharma: Our Formula for Success with McLaren Racing
